Literature DB >> 23647033

Development and validation of the Alcohol Myopia Scale.

Andrew Lac1, Dale E Berger.   

Abstract

Alcohol myopia theory conceptualizes the ability of alcohol to narrow attention and how this demand on mental resources produces the impairments of self-inflation, relief, and excess. The current research was designed to develop and validate a scale based on this framework. People who were alcohol users rated items representing myopic experiences arising from drinking episodes in the past month. In Study 1 (N = 260), the preliminary 3-factor structure was supported by exploratory factor analysis. In Study 2 (N = 289), the 3-factor structure was substantiated with confirmatory factor analysis, and it was superior in fit to an empirically indefensible 1-factor structure. The final 14-item scale was evaluated with internal consistency reliability, discriminant validity, convergent validity, criterion validity, and incremental validity. The alcohol myopia scale (AMS) illuminates conceptual underpinnings of this theory and yields insights for understanding the tunnel vision that arises from intoxication.

Entities:  

Mesh:

Year:  2013        PMID: 23647033     DOI: 10.1037/a0032535

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  3 in total

1.  Personality Traits Moderate Connections from Drinking Attitudes to Alcohol Use and Myopic Relief, Self-inflation, and Excess.

Authors:  Andrew Lac; Candice D Donaldson
Journal:  Subst Use Misuse       Date:  2019-01-14       Impact factor: 2.164

2.  Alcohol expectancies longitudinally predict drinking and the alcohol myopia effects of relief, self-inflation, and excess.

Authors:  Andrew Lac; Nathaniel Brack
Journal:  Addict Behav       Date:  2017-10-12       Impact factor: 3.913

3.  Observing Alcohol Myopia in the Context of a Trauma Film Paradigm: Differential Recall of Central and Peripheral Details.

Authors:  Anna E Jaffe; Christina M Harris; David DiLillo
Journal:  Alcohol Clin Exp Res       Date:  2019-08-19       Impact factor: 3.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.